Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-11-29
pubmed:abstractText
Circulating tumor cells (CTC) have been identified in several human malignancies, including malignant melanoma. However, whether melanoma CTC are tumorigenic and cause metastatic progression is currently unknown. Here, we isolate for the first time viable tumorigenic melanoma CTC and demonstrate that this cell population is capable of metastasis formation in human-to-mouse xenotransplantation experiments. The presence of CTC among peripheral blood mononuclear cells (PBMC) of murine recipients of subcutaneous (s.c.) human melanoma xenografts could be detected based on mRNA expression for human GAPDH and/or ATP-binding cassette subfamily B member 5 (ABCB5), a marker of malignant melanoma-initiating cells previously shown to be associated with metastatic disease progression in human patients. ABCB5 expression could also be detected in PBMC preparations from human stage IV melanoma patients but not healthy controls. The detection of melanoma CTC in human-to-mouse s.c. tumor xenotransplantation models correlated significantly with pulmonary metastasis formation. Moreover, prospectively isolated CTC from murine recipients of s.c. melanoma xenografts were capable of primary tumor initiation and caused metastasis formation upon xenotransplantation to secondary murine NOD-scid IL2R?(null) recipients. Our results provide initial evidence that melanoma CTC are tumorigenic and demonstrate that CTC are capable of causing metastatic tumor progression. These findings suggest a need for CTC eradication to inhibit metastatic progression and provide a rationale for assessment of therapeutic responses of this tumorigenic cell population to promising emerging melanoma treatment modalities.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/1R01CA113796, http://linkedlifedata.com/resource/pubmed/grant/1R01CA138231, http://linkedlifedata.com/resource/pubmed/grant/2P50CA093683, http://linkedlifedata.com/resource/pubmed/grant/P50 CA093683-07, http://linkedlifedata.com/resource/pubmed/grant/P50 CA093683-08, http://linkedlifedata.com/resource/pubmed/grant/P50 CA093683-09, http://linkedlifedata.com/resource/pubmed/grant/R01 CA113796-01A1, http://linkedlifedata.com/resource/pubmed/grant/R01 CA113796-02, http://linkedlifedata.com/resource/pubmed/grant/R01 CA113796-03, http://linkedlifedata.com/resource/pubmed/grant/R01 CA113796-04, http://linkedlifedata.com/resource/pubmed/grant/R01 CA113796-05, http://linkedlifedata.com/resource/pubmed/grant/R01 CA138231-01, http://linkedlifedata.com/resource/pubmed/grant/R01 CA138231-02, http://linkedlifedata.com/resource/pubmed/grant/R01 CA138231-03, http://linkedlifedata.com/resource/pubmed/grant/R01 CA138231-04
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1090-2104
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
26
pubmed:volume
402
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
711-7
pubmed:dateRevised
2011-10-6
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Isolation of tumorigenic circulating melanoma cells.
pubmed:affiliation
Transplantation Research Center, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural